Animal models for the investigation of the action of factors on bone metabolism
There is increasing interest from the world’s pharmaceutical industry in the problems of bone pathology, and many of the large companies and many smaller biotechnology companies have active bone research programmes. This chapter has been structured to encompass the requirements for both investigational (i.e. research) and preclinical assessment of factors with putative action (therapeutic or otherwise) on bone resorption or formation associated with bone modelling and remodelling. Models of fracture and repair of segmental defects are beyond the scope of this chapter. Investigational requirements centre around identification of an activity or validation of an activity identified in in vitro systems. Preclinical assessment centres around application of an activity to human disease. Under normal circumstances there is a progression from the investigational studies into preclinical assessment.
KeywordsBone Loss Bone Resorption Cancellous Bone Growth Plate Cynomolgus Monkey
Unable to display preview. Download preview PDF.
- 2.Yates, A.J., Gutierrez, G.E., Smolens, P. et al. (1988) Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. Journal of Clinical Investigation 81), 932–938.PubMedGoogle Scholar
- 4.Marcelli, C., Yates, A.J. and Mundy, G.R. (1990) In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. Journal of Bone and Mineral Research 10), 1087–1096.Google Scholar
- 5.Dunstan, C.R., Garrett, I.R., Adams, R. et al. (1995) Systemic fibroblast growth factor (FGF-1) prevents bone loss, increases new bone formation, and restores trabecular architecture in ovariectomized rats. Journal of Bone and Mineral Research 10(Suppl. 1), s198.Google Scholar
- 20.Food and Drug Administration (1994) Guidelines for preclinical and clinical evaluation of agents used in the prevention of post menopausal osteoporosis. Division of Metabolism and Endocrine Drug Products. Draft, April.Google Scholar
- 21.Jerome, C.P., Lees, C.J. and Weaver, D.S. (1995) Development of osteopenia in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 17 (Suppl.), 402S–408S.Google Scholar
- 23.Jerome, C.P., Carlson, C.S., Register, T.C. et al. (1994) Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry. Journal of Bone and Mineral Research 9), 527–540.PubMedGoogle Scholar
- 37.Waters, D.J., Caywood, D.D. and Turner, R.T. (1991) Effect of tamoxifen citrate on canine immobilization (disuse) osteoporosis. Veterinary Surg 20), 392–396.Google Scholar